secondary immunization with influenza virus A/PR/8/34 (PR8); we also identify the unexpressed V gene rearrangements in these hybridomas. We thereby can distinguish examples originating from different lymphocyte clones and identify examples originating from the same lymphocyte clone, generated in vivo. Interclonal comparisons measure the contribution of combinatorial joining, junctional diversity, and combinatorial association (Vu, V~) to diversity in this response. Intraclonal comparisons reveal the effects of a high rate of somatic mutation at both expressed V. and VL genes.
Materials and Methods
Antihemagglutinin Hybridomas. Hybridomas from mouse H36 and H37 were derived by fusion of spleen cells with Sp2/0-Agl4. Mice were immunized intraperitoneally 24 d before fusion and again, intravenously, 3 d before fusion, using 1,000 hemagglutinating units of influenza virus A/PR/8/34 (H 1N 1) each time (18) .
Genomie Blot Hybridizations. Hybridoma and BALB/c liver DNA were prepared as described by Perry et al. (19) . DNA were analyzed according to the method of Southern (20) . 12 ~g of DNA were digested with Eco RI (Bethesda Research Laboratories, Gaithersberg, MD), electrophoresed through a 0.7% agarose gel, transferred to nitrocellulose (Schleicher and Schueil, Inc., Keene, NH), and hybridized with 32P-labeled probes at 65 ° C. The probes were plasmid clones pJ 11 ( Fig. 5 ) (21), IVS (16) , and PRI (17) . pJ 11 was used to identify H chain rearrangements, IVS to identify ~ chain rearrangements, and PRI was used to identify U rearrangements. After a final wash in 30 mM NaCI/3.0 mM sodium citrate/0.1% sodium dodecyl sulfate (SDS) for 1 h at 65°C, filters were exposed to x-ray film at -70°C.
Isolation of Recombinant Clones. 300 ~g of DNA from hybridoma H37-77 was digested with EcoRI. Digested DNA was loaded intotrough of a 0.7% agarose gel and electrophoresed. Fractions of DNA were collected from a second trough located 10 cm from the origin. Fractions containing the 2.8 kb rearrangedJx fragment (unpublished observation) were identified by Southern blot analysis using pJ 11 as a probe. DNA from the appropriate fraction was cloned into the EcoRI site of ~gtWES (22, 23) . Recombinant phage were identified by hybridization to pJ11 (24) and plaque purified. A restriction map was made by end labeling the EcoRI insert with a-[s~P]dATP with the Klenow fragment of PolI (Boehringer Mannheim Biochemicals, Indianapolis, IN), digested with various restriction endonucleases, and electrophoresed on 5% polyacrylamide gels. Appropriate fragments were cloned into M 13mp8 or M 13mp9 and sequenced by the dideoxy method (25) .
RNA Preparation. RNA was prepared from cells grown in tissue culture or from subcutaneous tumors. ~3-5 × l0 s cells were grown in Dulbecco's modified Eagle's medium (Gibco Laboratories, Grand Island, NY) with 10% fetal calf serum. Cells were washed twice in phosphate-buffered saline and resuspended in 10 mi of RSB solution (0.01 M NaCI, 3 mM MgCI2, 0.01 M Tris, pH 7.4). 50 #1 of Triton X-100 was added and the cells vortexed for 15 s. Cells were lysed by douncing and the nuclei and cell debris removed by centrifugation at 500 g for 10 min at 4°C. 2 ml of a solution containing 0.5 M NaCI, 50/~M EDTA, 10 m Tris, pH 7.4, and 2.5% SDS were added to the supernatant and the supernatant extracted exhaustively with chloropane (chloroform/phenol, 1 : 1 vol/ vol, 0.05% 8-hydroxyquinoline, saturated with 0.01 M sodium acetate, 0.1 M NaCI and 1 mM EDTA). The RNA was then ethanol precipitated. RNA was isolated from subcutaneous tumors grown in BALB/c × NZB F1 mice as follows: Tumor tissue was rinsed in cold 0.9% NaCi, minced into small pieces, and transferred to 10 ml of cold 5% citric acid. The tissue was homogenized until an even suspension was obtained, and the suspension was passed through eight layers of cheesecloth. The cell debris was removed by centrifugation at 500 g for 10 min at 4°C. Supernatants were transferred to a polycarbonate tube (Beckman Instruments, Inc., Fullerton, CA) and centrifuged at 25,000 rpm for 2 h at 4°C. The pellet was washed with 0.01 M sodium acetate, pH 5, 0.05 M NaCI and dissolved in 25 ml of 0.01 M Tris, pH 7.4, 0.1 M NaCl, 1 mM EDTA, and 1.5% SDS. After a series of three chloropane extractions the RNA was ethanol precipitated.
Poly(A) ÷ RNA was prepared as follows: RNA prepared from tissue culture cells or subcutaneous tumors was removed from ethanol by centrifugation and resuspended in 2 ml of 1 mM EDTA, 10 mM Tris, pH 7.6, 0.1% SDS. The RNA was heat-shocked at 68°C for 5 rain, cooled to room temperature, and NaCI was added to a final concentration of 0.2 M. RNA solutions were passed through oligo(dT) Sepharose columns equilibrated in 0.2 M NaCI, 1 mM EDTA, 10 mM Tris, pH 7.6, 0.1% SDS. Poly(A) ÷ RNA was eluted with 1 mM EDTA, 10 mM Tris, pH 7.6, 0.1% SDS, ethanol-precipitated overnight at -20°C, resuspended in sterile H~O at 1 mg/ml, and stored at -70°C.
RNA Sequencing. RNA sequencing was carried out by extension of synthetic oligonucleotides homologous to ~ or "y constant regions. The K primer (5'-TGGATGGTGGGAA-GATG-3'), the y-crossreactive primer (5'-GGGGCCAGTGGATAGAC-3'), specific for -y1, y2a, and "y2b H chain mRNA, and the y3 primer (5'AGGGACCAAGGGATAGAC-3') were made by the phosphotriester method (26) .
Dideoxy sequencing was carried out using a modification of the procedure reported by Air (27) . Each base reaction was done separately in a 5 #l volume containingl00 mM Tris, pH 8.3, 140 mM KCI, 10 mM MgCI2, 10 mM dithiothreitol (DTT). Cold dCTP was added to each reaction to a concentration of 3 #M and a-[s~P]dCTP was added to a concentration of 2.4 #M (670 Ci/mmol; New England Nuclear, Boston, MA). G-specific reactions contained 50 #M dATP, 50 uM dTTP, and 10 #M dGTP; A-specific reactions contained 50 #M dGTP, 50 #M dTTP, and 10 #M ATP; C-specific reactions contained 50 #M dATP, dGTP, and dTTP; T-specific reactions contained 50 #M dATP, 50 #M dGTP, and 10 #M dTTP (P-L Biochemicais Inc., Milwaukee, WI). In addition, each reaction contained 0.3 #M of the appropriate dideoxynucleotide (P-L Biochemicals Inc.). ~2.5 #g (2.5 ~1) of poly(A) + mRNA and 10 ng of primer (0.5 #!) were mixed, boiled for 1 rain, and quick-cooled on ice water. 2 #1 of RNasin (20-30 U/ml; Promega Biotec, Madison, WI) and 1.5 #i of AMV reverse transcriptase (12-15 U/#I; Life Sciences, Inc., St. Petersburg, FL) were added and the mixture aliquoted equally into each of the four nucleotide mixes. After 30 min at 37°C, 1 #l of 1 mM dATP, dGTP, dCTP, and dTTP was added to each and the reaction mixtures returned to 37°C for 10 min. The reactions were stopped by the addition of an equal volume of 98% formamide, 0.3% xylene cyanoi, 0.3% bromophenoi blue. Samples were heat-shocked at 90°C and 3 gl were loaded on 80 cm, 6% polyacrylamide gradient gels (28) . The first 50 bases were resolved by a second sequence reaction containing a fourfold increase in the dideoxynucleotide concentration. Any uncertainties in the sequence ladder were resolved by carrying out a third sequencing reaction using a-sSS-dATP. For this method cold dCTP and a-[s~P]dCTP were eliminated and replaced with 0.05 #m dATP and 4 #M ~-sSS-dATP (500 Ci/mmol; New England Nuclear). Deoxynucleotide and dideoxynucleotide concentrations were the same except that dATP was replaced with dCTP.
A second method of obtaining H and L chain mRNA sequences, as described by Caton et al. (A. Caton, G. Brownlee, L. Staudt, and W. Gerhard, manuscript in preparation), was also used. H and L chain mRNA was completely extended using these oligonucleotides as primers. 40 ng of oligonucleotide were labeled with 10-20 U polynucleotide kinase (Boehringer Mannheim Biochemicals) and 13 uM 3,-[3~P]dATP (5,000 Ci/mmol; Amersham Corp., Arlington Heights, IL) in 100 mM Tris, pH 7.6, 10 mM MgCI2, 5 mM DTT, 0.1 mM spermidine, and 0.1 mM EDTA. After 1 h at 37°C the reaction was stopped by boiling for 5 min and quick-cooled on ice water. ~10-40 #g ofpoly(A) ÷ mRNA was added to the labeled primer, bringing the volume to 25.5 ul. Solutions were boiled for 1 min and quick-cooled in ice water. Reverse transcriptase buffer (12.5 t~l) containing 400 mM Tris, pH 8.3,560 mM KCI, 40 mM MgCI2 and 40 mM DTT, 5 ~,! of 5 mM dATP, dGTP, dCTP, and dTTP, 4 IA of RNasin (20 U/#I) and 3 ul of reverse transcriptase (12-15 U/ vl) were added to the RNA solution. After 2 h at 37°C the mRNA was digested with 25 #1 RNase (0.5 mg/ml in 50 mM EDTA) at 37°C for 30 rain. The cDNA were extracted with phenol/chloroform (1:1 vol/vol, saturated with 10 mM Tris, pH 7.2, 10 mM EDTA, 10 mM NaCl), ethanol-precipitated, and electrophoresed on a 5% polyacrylamide, 7 M urea gel for 3 h at 1,200 V. H and L chain cDNA transcripts were identified by exposure to film at room temperature. The cDNA were eluted from the appropriate gel slices in 2 M ammonium acetate by shaking overnight at 37 °C. The cDNA were ethanol precipitated and washed extensively before we carried out Maxam and Gilbert (29) (Fig. 1) . The 7183 V. family is one of seven families defined in the mouse and consists of 10-12 V. genes (31) . This V. gene is assigned to the 7183 family based on having >80% sequence homology to the known members of this family, mRNA dot blot analysis supports this assignment, as mRNA isolated from these hybridomas hybridizes to a V. gene from the 7183 family and not to V. genes from other families (data not shown). The V. gene from each member of this set has rearranged to the DFL16.2 (7) and J. Hybridomas H36-5, 7, and 17 express a V. gene of the S107 family ( Fig. 2 ) (31, 32) . This assignment is based on their having >80% sequence homology to the genes of this family. The expressed V. gene of this family hybridizes in an mRNA dot blot analysis with a gene from this family but not to genes of other V. families (data not shown). Of the four V. genes in the S107 family (32), the expressed gene in these hybridomas is most homologous (94-97%) to V.-V11. Thus, the hybridomas of this set express mutants of the V 11 gene. This V. gene has rearranged to a D gene closest in homology to the DQ52 gene (6) and to the J.1 gene segment in each hybridoma. In addition, all three hybridomas have identical V.-D. and D.-J. junctions. The DQ52 germline gene segment consists of 10 nucleotides; however, in these examples only five nucleotides are spliced to the V and J genes, and the second codon of D is a hybrid codon formed by both the D and J genes.
The three hybridomas from mouse H37 can be assigned to two sets, based on both H and L chain gene usage. One set includes hybridomas H37-77 and 63. Both have rearranged the same V. gene (Fig. 3 ). This gene is 90% homologous to the V. gene rearranged in hybridomas H36-1, 4, 15, and 18, and the cloned H37-77 V. gene, when used as a probe in a Southern blot analysis of BALB/c DNA, hybridizes to restriction fragments of sizes characteristic of the 7183 V. family (data not shown). It is unlikely that the expressed V. gene from hybridomas H36-1, 4, 15, and 18 and the expressed gene in H37-77 and 63 are the same, since the size of the productive J. rearrangements in these hybridomas (as determined by Southern blot analyses) shows a difference in the location of the ~mily to the DFL16.1 and Jn3 genes. H37-85 has rearranged a V. The Jn rearrangements (H +, H-), J, rearrangements (x+, x-), and upstream rearrangements were detected by Southern blot hybridization using the probes described (Materials and Methods). The H chain rearrangement for all hybridomas were detected using EcoRI-digested hybridoma DNA. L chain rearrangements for the H36 hybridomas were detected using HindIII-digested hybridoma DNA (Huppi, manuscript in preparation), whereas L chain rearrangements for the H37 hybridomas were detected using HindIII/BamHI-digested hybridoma DNA. All upstream rearrangements were detected after BamHI digestion of hybridoma DNA. Brackets indicate clonally related hybridomas.
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EcoRI site 5' of the rearranged V. genes (Table I) . Therefore, at least two members of the 7183 family are used in the response to the Sb site of HA. Both H37-77 and 63 have rearranged the expressed V. gene to the DFL16.2 andJ.3 gene segments. H37-85 expresses a VH gene with only 62-65% homology to the V, genes of the S107 and 7183 VH families (Fig. 3) . It is closest in homology (96.5%) to the V. gene used in the BALB/c antiarsonate response (1210.7 V.) (33) . This BALB/c antiArsonate V. gene hybridizes in a Southern blot analysis to a set of restriction fragments whose sizes are characteristic of the 3660 VH family (31, 33) . Thus, a third V, family can contribute to the anti-HA (Sb) response. This V. gene has rearranged to a D. gene with ~40% homology to any known germline D, gene and to the J.2 gene segment. This D. segment may be coded for by an as yet unidentified germline DH gene or it may have been derived from a known germline gene, such as DSP2 (7), that has been altered by the addition of nucleotides and somatic mutation.
All seven H36 hybridoma antibodies express v~21C-J~2 L chains. H37-77, 63, and 85 express V~ genes that are 97-99% homologous to the V~21C germline gene sequence (34) (Fig. 4) and encode amino acids that distinguish V~21C from all other V~21 subgroups (35, 36) . This gene has rearranged to J~4 in H37-85 and to J~5 in H37-77 and 63. The V~21C-J~5 junction in H37-77 and 63 is unusual in that at least two and possibly as many as five extra nucleotides are contributed by the V~21C germline gene to create a proline codon not seen in any other V~2 IC sequence.
Genetic Rearrangements at H and L Chain Loci. The nature of rearranged DNA at both expressed and unexpressed loci is for the most part consistent with the idea that these 10 hybridomas originated from four different precursors (see Fig. 6 ). A previous study (30) suggested that four hybridomas from mouse H36 Comparison of V,21C mRNA sequences from hybridomas H37-ranged to the J,4 gene, and H37-77 and 63 have rearranged to the J,5 gcne.
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85, H37-77, and H37-63 to a germline V,21C-J,2 DNA sequence from CDRsare enclosed in boxes. plasmacytoma PC3741 (Huppi, manuscript in preparation). H37-85 has rear-FIGURE 5. Southern blot hybridization of a JH probe, pJ 11, to DNA from the seven V,21 Cassociated hybridomas of mouse H36, BALB/c liver DNA, and Sp2/0-Agl4 DNA after digestion with EcoRl. All hybridomas share a 6.5 kb band that corresponds to an unrearranged JH locus, which may be derived from either the hybridoma or from contaminating host tissue. In addition, some hybridomas have a 5.6 kb rearrangement derived from the fusion partner Sp2/0-AgI4. H36-5 DNA shows a faint band at 2.9 kb.
(H36-1, 4, 15, and 18) are derived from a c o m m o n lymphocyte precursor. This conclusion was based on shared K +, K-, and U r e a r r a n g e m e n t s (Table I) . T h e remaining three hybridomas from this mouse (H36-5, 7, and 17) share certain V, amino acid substitutions (30) but, as they lack K-, and U r e a r r a n g e m e n t s (Table I) , their relationship to each other and to the other four H 3 6 hybridomas was uncertain. O f the three H 3 7 hybridomas, H37-63 and H37-77 appear to be clonally related, since they share a K +, K-, and two U r e a r r a n g e m e n t s (Table I ).
T h e 1.7 kb J, r e a r r a n g e m e n t is the expected size for the V~21C-J~5 joining and likely represents the K + allele. T h e 5.6 kb band must therefore represent a shared K-allele. J , gene r e a r r a n g e m e n t s were examined for all 10 hybridomas (Fig. 5 and T a b l e I). H y b r i d o m a s H36-4, 1, 15, and 18 each have two rearrangements. All four share a 5.0 kb r e a r r a n g e m e n t , three share a 2.3 kb rearrangement, and H36-4 has a unique rearrangement of 2.1 kb. The 5.0 kb rearrangement was cloned into the EcoRI site of hgtWES and used as a probe in a Southern blot of EcoRI-digested BALB/c liver DNA. This DNA clone hybridizes to a set of restriction fragments characteristic of the DFL 16/SP2 families of D genes (data not shown), indicating that the 5.0 kb Jx rearrangement shared by H36-1, 4, 15, and 18 is a nonproductive D-J rearrangement, thus supporting the clonal relatedness of these four hybridomas. The 2.3 kb rearrangement of H36-1, 15, and 18 and the 2.1 kb rearrangement of H36-4 must therefore be the productive VH-DH-JH rearrangements.
H36-17 and 5 each have just one hybridoma-specific JH rearrangement (4.9 kb and 2.9 kb, respectively; Fig. 5 and Table I ). Therefore, these must be productive rearrangements. H36-7 also has a 4.9 kb J. rearrangement. As this rearrangement is shared by H36-17, it is probably the productively rearranged VH in this hybridoma. In addition, H36-7 has a second rearrangement of 2.4 kb, which must be nonproductive. The hybridomas of mouse H37 also share rearrangements at theJH locus (Table I) . H37-77 and H37-63 each have a single rearrangement of 2.8 kb, while hybridoma H37-85 has a unique rearrangement of 2.4 kb. Since these are the only rearrangements in these hybridomas, each must represent a productively rearranged V, gene.
Several unique rearrangements among members of a set have been found. For instance, hybridomas H36-1, 15, and 18 share a 2.3 kb productive H chain gene rearrangement while H36-4 has a 2.1 kb productive rearrangement (Table I) . The reason for the differences in size of these restriction fragments is not certain. Southern blot analysis of HindIII-digested DNA hybridized with pJ11 showed the same difference in size between the productive rearrangements, suggesting that it is not due to point mutation but more likely to either a deletion of DNA from H36-4 or an insertion of DNA into H36-1, 15, and 18, before their divergence, A similar pattern exists among the second set of hybridomas from mouse H36. H36-7 and 17 share a 4.9 kb productive rearrangement, while H36-5 has a 2.9 kb productive rearrangement (Table I) . This also may be explained by insertion, deletion, or point mutation. These three hybridomas also differ at their nonproductive loci. The lack of H-and K-rearrangements in two of these three hybridomas (Table I) can be explained by chromosome loss either before or after cell fusion. Alternatively, lymphocytes may continue to rearrange their H and L chain gene loci after productive rearrangements have occurred, thereby accounting for unshared rearrangements.
Discussion
The secondary antibody response to the infleunza HA molecule is highly diverse. It is estimated (18) that the BALB/c mouse has the potential of producing at least 500 different antibodies to any of the four major antigenic sites on the HA molecule. To understand the genetic basis of this diversity, we have analyzed the V region sequences of hybridomas secreting HA-specific antibodies, focusing on examples directed to the antigenic site Sb [HA (Sb)]. This survey of diversity includes analysis of the contribution of germline genes, combinatorial joining, and somatic mutation. Germline diversity is assessed by the V region differences found between members of different clones of lymphocytes; somatic mutation is assessed by differences between members of the same clone of lymphocytes. Hybridomas from different individuals, i.e., mouse H36 or H37, are one source of examples of independent origin, while hybridomas from a single mouse may include examples of the same or different clonai origin. We are able to determine whether hybridomas from a single individual have originated from the same or different precursors on the basis of Vn region sequence. Because of the considerable flexibility in forming a complete Vn region gene, lymphocytes that have joined the same V,, DH, and J. gene segments and form identical junctions must be clonally related. Since these rearrangements are fixed, lymphocytes that differ in these respects must be of separate clonal origin.
Interclonat Diversity Among HA (Sb) Antibodies. The V. and V, loci of the mouse are highly complex. Both loci are estimated to consist of a few hundred genes. These genes fall into families in which the average nucleic acid sequence homology between families is ~60% (31). The homology of genes within a family is much higher, averaging >85%. The size of families varies from ~40-50 genes (the V.-J558 family) to just one (such as VK167 [37] or Vxl and V~2 [38] ). These germline complements of V genes provide an important source of diversity, one that is further amplified by the combinatorial joining of a given V gene with different D., J., or JK gene segments. The interclonal comparison of HA (Sb) antibodies reveals the extent of germline diversification. These antibodies have V. regions drawn from three different families (designated S107, 7183, and 3660 [31 ] ). Different DH genes and JH genes are also represented within these Vr~ regions, and the junctions of these gene segments show both flexibility of joining and apparent nucleotide additions (N sequences; Fig. 1, 2, and 3) . Different V, gene products are also found among HA (Sb) antibodies. The V,21C subgroup, other V,21 subgroups, and at least one other V~ group (V~8) are represented (18 and S. Clarke, W. Gerhard, and M. Weigert, manuscript in preparation).
To assess the contribution of combinatorial joining, one must compare examples that share a particular V gene segment. In this survey all examples express the product of a single V~ gene, VK21C. Combinatorial joining does add to the diversity of these antibodies; in this sample V,21C has joined to either J,-2, J,-4, or J~-5 (Fig. 6) . Combinatorial joining also diversifies V, regions. Primary and secondary HA (Sb) antibodies are frequently encoded by the Vn-V11 gene, which has been found to be joined to a variety of DH gene segments and two different J. gene segments (Fig. 2 and Clarke, manuscript in preparation). A further amplification of germline diversity arises from the combinatorial association of different V. and VL regions. This is shown in the comparison of the V,21C-associated HA (Sb) antibodies (Fig. 6 ). These VK21C L chains are paired with H chains from the three V. families described above.
The effect of germline diversity on the specificity of these antibodies can be evaluated. These monoclonal antibodies have been tested for binding to mutants of the PR8 virus (18) , each mutant differing from PR8 by a single amino acid substitution (39) . This analysis provides a reactivity pattern for each antibody from which one can infer the site of binding. Further, as these antibodies usually show reduced binding to different mutant viruses, these reactivity patterns also define the fine specificity of a given antibody. The extent to which sequence differences affect specificity and fine specificity is obviously limited by the assay. For example, antibodies with the same reactivity patterns might have distinguishable specificities if tested against additional PR8 mutants. However, within the context of this panel of mutant PR8 viruses, it is apparent that the V~21C region plays a dominant role in antigen binding (Fig. 6 ). All of these antibodies bind to the Sb site in spite of major sequence differences in V. regions. In particular, H36-5 and H36-1 have equivalent reactivity patterns even though they differ vastly with regard to their Vn regions (Fig. 6 ). It seems likely that these antibodies were primarily selected for by immunization with PR8, because of the contribution of V~21C to their binding sites. This interpretation is supported by the pattern of somatic mutation in the V~21C and V, genes coding for these V regions. Somatic Mutation and Intraclonal Diversity. The V, region sequences have identified sets of clonally related hybridomas from mice H36 and H37. These clonal relationships are substantiated by shared nonproductive ~ and H chain gene rearrangements and upstream K rearrangements (Table I) . Nevertheless, clonally related examples differ significantly in their Vn and V~ sequences (Figs.  1-4) . By definition these differences are the result of somatic mutation. By comparing the sequences and reactivity patterns of hybridomas of a single clone, one can reach several conclusions concerning the nature of somatic mutation and can assess the effect of somatic mutation on fine specificity.
The H36 hybridomas are members of two clones. Members of each clone have both shared mutations and unique mutations, because of sequential accumulation of mutations during clonal expansion. Two comprehensive genealogic trees that include all mutations in V. and VL coding regions are shown in Fig. 7 . The clone that includes hybridomas H36-5, 7, and 17 stems from a precursor that rearranged the V.-V 11 and V,21C genes. These three hybridomas have accumulated 20, 12, and 19 V.-coding region mutations and 9, 8, and 15 Vccoding region mutations (Fig. 7) . The clone that includes hybridomas H36-1, 4, 15, and 18 is derived from a precursor that has rearranged a gene of the 7183 V. family and the V,21C gene. The total number of Vu mutations cannot be determined for this clone in the absence of a germline sequence. However, we can compare the number of V, and V, mutations by comparing the points at which different progeny in this clone have diverged. The number of mutations that have accumulated in VH and V, after divergence are nearly the same (Fig. 7) . These observations suggest that the rate of somatic mutation must be similar at both V. and VL loci. To account for the extent of mutation at the V, locus of these cells, the mutation rate must be at least 10 -3 mutations per base pair per division (30) . The rate of mutation can be estimated at the V. locus of hybridomas H36-5, 7,.and 17, since all V. mutations for these are known. These three hybridomas have accumulated an average of 17 coding region mutations. If these lymphocytes had divided every 18 h from the time of primary immunization to the time of fusion (24 d), then the rate of mutation at this V~ gene would be 1.5 x 10 -3 per base pair per division. A major uncertainty in this estimate is the number of divisions during which mutation takes place. For example, mutations may accumulate before antigen selection, as suggested by studies on a pre-B cell line (10) . Furthermore, the precursors of these clones may have been stimulated by unknown antigens, thereby accumulating mutations before exposure to influenza virus. However, even if the number of divisions were doubled, the calculated rate of mutation would remain high (7.5 x 10-4), and would still be five to six orders of magnitude above the spontaneous mutation rate in eukaryotic DNA (4o).
The nature and distribution of mutations in these V regions suggests that many of them are selected for by antigen. Analysis of the noncoding mutations, i.e., silent and flanking sequence substitutions, has shown these to be randomly distributed in and around these V,21C genes (K. Huppi, S. Clarke, S. Litwin, L. Staudt, W. Gerhard, and M. Weigert, manuscript in preparation). If replacement mutations also occur at random in the V,21C gene, then selection of replacement mutations should influence both the ratio of replacement to silent mutations (R/ S) and the distribution of replacement mutations, since antigen-selected mutations must be replacement types and should be located predominantly in complementary-determining regions (CDR). In addition, these features of antigenselected mutations should be found in the V, genes and not in the V. genes, if the V,21C plays the dominant role in determination of the specificity of these antibodies, as argued above. Indeed, the V,21C mutations strongly indicate antigen selection: first, the R/S ratio is 10, and, second, 80% of the replacement mutations are in CDRs (Huppi, manuscript in preparation). In contrast, the V. regions of H36-5, 7, 17 (for which a germline sequence is known) have an R/S ratio of 1, and only 33% of the replacement mutations are in CDRs. Neither value is significantly different from that expected by a random distribution of mutations.
Surveys of V,21C-associated anti-HA (Sb) antibodies (Huppi, manuscript in preparation) show that all cases have accumulated at least one CDR mutation, including H2-6C4, a rare example of an IgM antibody. Thus, it appears that mutation of V,21C is required to create this specificity, an idea consistent with the recent observation (Staudt and Gerhard, manuscript in preparation) that V,21C antibodies are rare in the primary response to HA, but highly represented in the secondary response. That somatic mutation can influence specificity is seen by a comparison of the reactivity patterns between members of all three clones. The most striking differences are between hybridomas H37-77 and 63. H37-77 is unable to bind six of the nine Sb mutant virus, whereas H37-63 can bind all but one (Fig. 6) . If somatic mutants of V,21C were indeed exclusively selected for by antigen, then at the initial stages of diversification, mutations should be predominantly replacement types in CDR. At later stages of diversification, additional CDR replacements may confer a selective advantage because of further modification of a combining site. However, it seems likely that most mutants with additional CDR amino acid substitutions would be at a selective disadvantage once a well-fitting combining site is formed. Hence, at later stages of diversification one would expect a preponderance of flanking and silent mutations. The order in which mutations have accumulated in these clones fits this model. The shared V,21C mutations presumed to have occurred early during clonal expansion, have a high R/S ratio and are predominantly replacement mutations in CDRs (Huppi, manuscript in preparation). In contrast, the unique mutations in each hybridoma have a low R/S ratio and are predominantly flanking region or silent coding region mutations.
Summary
This study focuses on 10 BALB/c anti-influenza virus (A/PR/8/34) hemagglutinin antibodies that have light chains encoded by the same variable region K chain (V,) gene, V,21C. A comparison of antibodies from lymphocytes of independent origin reveals the contribution of germline diversity (combinatorial joining and association) to this response. Although combinatorial joining and association contribute to sequence diversity, they appear to have little effect on the fine specificity of these antibodies.
Somatic mutation, in addition to contributing to the sequence diversity of these antibodies, creates differences in their fine specificity. The extent of mutation and its effect on fine specificity can be seen by comparing antibodies of lymphocytes from the same clone. These intracional comparisons also indicate that somatic mutation is an ongoing process occurring at a high rate (estimated to be at least 10 -3 mutations per base pair per division) in the expressed V region heavy chain (V,) and V~ genes. Furthermore, both the nature and distribution of these mutations suggest that amino acid replacement mutations in the light but not the heavy chain are selected for by antigen. 28 December 1984. 
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